2023

Successful treatment of mastocytic anaphylactic episodes with reduction of skin mast cells after anti-IgE therapy

G. Paraskevopoulos, E. Sifnaios, K. Christodoulopoulos, F. Mantopoulou, M. Papakonstantis, D. Sabaziotis

Vol. 45 (No. 2) 2013 March

Case Report

SUMMARY

Mastocytosis is a clonal disease derived from hematopoietic bone marrow progenitor cells.
Clinical manifestations of the disease vary greatly depending on tissue involvement. Omalizumab is a recombinant humanized monoclonal anti-IgE antibody licensed in the treatment of asthma with increasing reports of clinical efficiency in other allergic diseases. We describe a case of a patient with mastocytosis responsive clinically and patho-physiologically after anti-IgE treatment.

Full text PDF

Table of Content: Vol. 45 (No. 2) 2013 March

Letter to the Editor

Safety of allergen injection immunotherapy in real life

F. Borghesan, G. Manzotti

Download PDF

Case Report

Food protein-induced enterocolitis syndrome due to banana: an uncommon entity

M.Don, G. Longo

Download PDF

Case Report

Severe anaphylaxis to sheep’s milk cheese in a child desensitized to cow’s milk through specific oral tolerance induction

S.Tripodi, P.Comberiati, A.Di Rienzo Businco, A. Bianchi, F. Bondanini, V. Sargentini, G. Pingitore, C. Ballabio, P. Restani, S.Miceli Sopo

Download PDF

Case Report